In the present study, SEPT9 was associated with hypermethylation (promoter and gene body region) in fusion-positive PCa as compared to fusion-negative tumors, and gene expression was also higher in fusion-positive cases. The gene discussed is SEPTIN9; the disease is posterior cortical atrophy.